Background/Objectives: To analyze the Pharmaceuticals and Agricultural sector of India which, before implementation of WTO’S TRIPS agreement, was able to develop cheap outputs by “riding-on” research and technological advancements of other nations.
Methods/Statistical analysis: The methodology of this study is descriptive in nature and therefore no statistical approaches have been used in majority of the paper except for digression into the analysis of IP protection on FDI inflows in the BIMSTEC countries. For that analysis linear OLS regression model has been employed and the results have been computed using E-Views. The major part of this study has been the data collection which has been sourced from CMIE, RBI, WIPO and DGCIS databases.
Findings: From 1990 to 2008, there has been a gradual rise in imports and exports of pharmaceutical products in India. However the share of Drugs and chemicals in the total exports has decreased after 2005, post TRIPs transition. Moreover the regression analysis of FDI inflows with IP protection shows that the countries tend to invest more in the countries with stronger intellectual property protection.
Application/Improvements: The models provided in way forward can very well be employed in any of the emerging and least developed countries. The models discussed are very much relevant for sub-African and African countries where the access to medicines and food is a major concern